For the BARD1-XPD (a.k.a. ERCC2) interaction in the first breast cancer study (p-value 0.014), BARD1 as well as paralogs ERCC2 and ERCC1 refer to keyword "dna repair" (p-value 0.009). This evidence concerns the gene ERCC2 and breast carcinoma.